Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
Roland Derwand, Martin Scholz, Vladimir Zelenko
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 6, pp. 106214-106214
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

COVID-19: A Multidisciplinary Review
Nour Chams, Sana Chams, Reina Badran, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 359
The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis
Inga Weßels, Benjamin Rolles, Lothar Rink
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 319
The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 136
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 400-400
Open Access | Times Cited: 72
Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
Marina Vogel-González, Marc Talló-Parra, Víctor Herrera-Fernández, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 562-562
Open Access | Times Cited: 98
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)
Peter A. McCullough, Paul Alexander, Robin Armstrong, et al.
Reviews in Cardiovascular Medicine (2020) Vol. 21, Iss. 4
Open Access | Times Cited: 80
The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
E. Manivannan, Chandrabose Karthikeyan, N. S. Hari Narayana Moorthy, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 60
Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc
Salvatore Corrao, Raffaella Mallaci Bocchio, Marika Lo Monaco, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1261-1261
Open Access | Times Cited: 59
Zinc and selenium supplementation in COVID-19 prevention and treatment: a systematic review of the experimental studies
Erica Balboni, Federico Zagnoli, Tommaso Filippini, et al.
Journal of Trace Elements in Medicine and Biology (2022) Vol. 71, pp. 126956-126956
Open Access | Times Cited: 59
Zinc in Human Health and Infectious Diseases
Martina Maywald, Lothar Rink
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1748-1748
Open Access | Times Cited: 59
A pilot double‐blind safety and feasibility randomized controlled trial of high‐dose intravenous zinc in hospitalized COVID‐19 patients
Oneel Patel, Vidyasagar Chinni, Hanna J El-Khoury, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 5, pp. 3261-3267
Open Access | Times Cited: 55
Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study
Andrew Ip, Jaeil Ahn, Yizhao Zhou, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 53
COVID-19 pandemic: Can zinc supplementation provide an additional shield against the infection?
Mohammed S. Razzaque
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 1371-1378
Open Access | Times Cited: 48
Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials
Jennifer Hunter, Susan Arentz, Joshua Z. Goldenberg, et al.
BMJ Open (2021) Vol. 11, Iss. 11, pp. e047474-e047474
Open Access | Times Cited: 47
Zinc2+ion inhibits SARS-CoV-2 main protease and viral replicationin vitro
Love Panchariya, Wajahat Khan, Shobhan Kuila, et al.
Chemical Communications (2021) Vol. 57, Iss. 78, pp. 10083-10086
Closed Access | Times Cited: 40
Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Foods (2022) Vol. 11, Iss. 18, pp. 2884-2884
Open Access | Times Cited: 34
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection
Brian C. Procter, Casey Ross, Vanessa Pickard, et al.
Reviews in Cardiovascular Medicine (2020) Vol. 21, Iss. 4
Open Access | Times Cited: 48
Zinc and Respiratory Viral Infections: Important Trace Element in Anti-viral Response and Immune Regulation
Fatemeh Sadeghsoltani, Iraj Mohammadzadeh, Mir-Meghdad Safari, et al.
Biological Trace Element Research (2021) Vol. 200, Iss. 6, pp. 2556-2571
Open Access | Times Cited: 38
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, et al.
Infectious Diseases and Therapy (2021) Vol. 10, Iss. 4, pp. 1837-1885
Open Access | Times Cited: 33
Therapeutic Potential of Nutraceuticals and Dietary Supplements in the Prevention of Viral Diseases: A Review
S. P. Singh, Prithwish Kola, Dalveer Kaur, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 32
PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID-19
B. Rabindran Jermy, Vijaya Ravinayagam, Dana Almohazey, et al.
Applied Clay Science (2021) Vol. 216, pp. 106333-106333
Open Access | Times Cited: 32
The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients
Luis Ayerbe, Carlos Risco-Risco, Salma Ayis
Internal and Emergency Medicine (2020) Vol. 15, Iss. 8, pp. 1501-1506
Open Access | Times Cited: 36
Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review
Chadwick C. Prodromos, Tobias Rumschlag
New Microbes and New Infections (2020) Vol. 38, pp. 100776-100776
Open Access | Times Cited: 33
Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study
Khalid Al Sulaiman, Ohoud Aljuhani, Abdulrahman I. Al Shaya, et al.
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 30
Metal-based strategies for the fight against COVID-19
Hongyan Li, Shuofeng Yuan, Xueying Wei, et al.
Chemical Communications (2022) Vol. 58, Iss. 54, pp. 7466-7482
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top